Advanced Biomedical Engineering
Online ISSN : 2187-5219
ISSN-L : 2187-5219
Developing Printable and Non-Toxic Gelatin-Alginate Ink for 3D Printing using Calcium Chloride Pre-Crosslinking
Dung Quoc NGUYENNghia Thi Hieu PHANHa Le Bao TRAN
Author information
JOURNAL OPEN ACCESS

2024 Volume 13 Pages 293-300

Details
Abstract

The utilization of calcium chloride (CaCl2) pre-crosslinking in gelatin-alginate ink holds promise for creating printable ink formulations that exhibit good printability and do not compromise the viability of cells. This study focuses on the development of ink formulations using CaCl2 pre-crosslinking, ensuring both printability and safety against cytotoxicity. In this study, the gelatin-alginate hydrogel was combined with varying concentrations of CaCl2 (60 mM, 70 mM, and 80 mM) to create four ink formulations. Then, the printability of these inks was assessed, and the best formulation was selected for printing the desired structure. Subsequently, cytotoxicity and cell viability of the printed structure were evaluated. The results suggested that among these formulations, the ink containing gelatin: alginate: 70 mM CaCl2 in a 1 : 1 : 0.5 volumetric ratio exhibited good printability characterized by smooth and straight ink filaments, with a printability (Pr) value of 0.93 ± 0.044. Importantly, cytotoxicity assessments demonstrated that this ink was non-toxic to L929 cells, with a relative growth rate of 83.29%. Furthermore, viability studies using human fibroblast cells showed sustained cell viability within the scaffold structure for at least 24 hours under standard culture conditions. These results highlight the potential of using the gelatin-alginate ink formulation in extrusion-based three-dimensional (3D) printing methods for constructing scaffolds in tissue engineering applications.

Content from these authors
© 2024 Japanese Society for Medical and Biological Engineering

Copyright: ©2024 The Author(s). This is an open access article distributed under the terms of the Creative Commons BY 4.0 International (Attribution) License (https://creativecommons.org/licenses/by/4.0/legalcode), which permits the unrestricted distribution, reproduction and use of the article provided the original source and authors are credited.
https://creativecommons.org/licenses/by/4.0/legalcode
Previous article Next article
feedback
Top